Ando M, Kol S, Kokia E, Ruutiainen-Altman K, Sirois J, Rohan R M, Payne D W, Adashi E Y
Department of Obstetrics and Gynecology, University of Maryland School of Medicine, Baltimore 21201, USA.
Endocrinology. 1998 May;139(5):2501-8. doi: 10.1210/endo.139.5.5988.
This laboratory has previously shown that interleukin-1 (IL-1), a putative intermediary in the ovulatory process, is capable of up-regulating PG biosynthesis by cultured whole ovarian dispersates from immature rats. In part, this phenomenon was attributable to the stimulation of ovarian phospholipase A2 activity. In this communication we examine the possibility that the PG-promoting property of IL-1 is also due to the up-regulation of PG endoperoxide synthase (PGS), the rate-limiting step in prostanoid biosynthesis. The in vivo expression of ovarian PGS-2 transcripts in the course of a simulated estrous cycle rose abruptly to a peak (35-fold increase over the control value; P < 0.05) 8-12 h after hCG administration (i.e. before or during projected ovulation). PGS-1 transcripts, in turn, were not significantly altered during the periovulatory period. Treatment of cultured whole ovarian dispersates with IL-1beta resulted in dose- and time-dependent up-regulation of PGS-2 transcripts (as well as of immunoreactive PGS-2 protein and PGE2 accumulation), characterized by an ED50 of 2 ng/ml and a maximal (72-fold) increase at 10 ng/ml. Although treatment with IL-1beta also led to an increase in PGS-1 transcripts and immunoreactive PGS-1 protein, the relative magnitude of the effect was markedly reduced compared with that of PGS-2. Cotreatment with an IL-1 receptor antagonist completely reversed the IL-1 effects, thereby suggesting mediation via the IL-1 receptor. The ability of IL-1 to up-regulate PGS-2 transcripts proved relatively specific, in that other cellular regulators (insulin-like growth factor I, activin A, endothelin-1, transforming growth factor-alpha, tumor necrosis factor-alpha, vascular endothelial growth factor, leukemia inhibitor factor, hepatocyte growth factor, or keratinocyte growth factor) were not effective. The optimal IL-1 effect required heterologous contact-dependent coculturing of granulosa and thecal-interstitial cells. Taken together, these observations 1) reaffirm (by molecular probing) the granulosa cell as the primary site of ovarian PGS-1 and PGS-2 expression, 2) document an increase in ovarian PGS-2 transcripts before ovulation, and 3) reveal a marked dependence of ovarian PGS (2 >> 1) transcripts, proteins, and activity on IL-1. The effects of IL-1 proved relatively specific, contingent upon somatic cell-cell cooperation, dose and time dependent, and IL-1 receptor mediated. These results are compatible with the proposition that the PG-promoting property of IL-1 is due, in large measure, to the activation of ovarian PGS transcription and translation. The ability of IL-1 to up-regulate ovarian PGS, an obligatory component of ovulation, is in keeping with the idea that IL-1 may constitute an intermediary in the ovulatory process.
本实验室先前已表明,白细胞介素-1(IL-1)作为排卵过程中的一种假定介质,能够上调未成熟大鼠培养的全卵巢分散细胞中前列腺素(PG)的生物合成。部分而言,这种现象归因于对卵巢磷脂酶A2活性的刺激。在本通讯中,我们研究了IL-1促进PG生成的特性是否也归因于PG内过氧化物合酶(PGS)的上调,PGS是类前列腺素生物合成中的限速步骤。在模拟发情周期过程中,卵巢PGS-2转录本的体内表达在人绒毛膜促性腺激素(hCG)给药后8 - 12小时(即预计排卵前或排卵期间)突然升至峰值(比对照值增加35倍;P < 0.05)。而PGS-1转录本在排卵前期未发生显著变化。用IL-1β处理培养的全卵巢分散细胞导致PGS-2转录本(以及免疫反应性PGS-2蛋白和PGE2积累)呈剂量和时间依赖性上调,其半数有效剂量(ED50)为2 ng/ml,在10 ng/ml时最大增加72倍。尽管用IL-1β处理也导致PGS-1转录本和免疫反应性PGS-1蛋白增加,但与PGS-2相比,其作用的相对幅度明显降低。与IL-1受体拮抗剂共同处理完全逆转了IL-1的作用,从而表明是通过IL-1受体介导的。IL-1上调PGS-2转录本的能力被证明具有相对特异性,因为其他细胞调节因子(胰岛素样生长因子I、激活素A、内皮素-1、转化生长因子-α、肿瘤坏死因子-α、血管内皮生长因子、白血病抑制因子、肝细胞生长因子或角质形成细胞生长因子)均无效。IL-1的最佳作用需要颗粒细胞与卵泡膜间质细胞进行异源接触依赖性共培养。综上所述,这些观察结果:1)(通过分子探测)再次证实颗粒细胞是卵巢PGS-1和PGS-2表达的主要部位;2)记录了排卵前卵巢PGS-2转录本的增加;3)揭示了卵巢PGS(2 >> 1)转录本、蛋白质和活性对IL-1的显著依赖性。IL-1的作用被证明具有相对特异性,取决于体细胞间的协作、剂量和时间依赖性以及IL-1受体介导。这些结果与以下观点一致,即IL-1促进PG生成的特性在很大程度上归因于卵巢PGS转录和翻译的激活。IL-1上调卵巢PGS(排卵的一个必需成分)的能力与IL-1可能构成排卵过程中的一种介质的观点相符。